Panoramica di mercato

The global gastrointestinal endoscopy market, valued at $13.40 miliardi di dollari 2021, is projected to reach $25.75 miliardi di 2031, con un CAGR di 6.24% during the forecast period of 2022-2031. This growth is driven by factors such as the increasing prevalence of gastrointestinal diseases, a preference for minimally invasive surgeries, growing demand for capsule endoscopy, the shift from reusable to disposable endoscopes, and technological advancements in robot-assisted endoscopes and AI-based devices.

The market is currently in a developed phase, with opportunities arising from the demand for single-use endoscopes, integration of robotics and AI, and the popularity of capsule endoscopy. Key trends include the shift towards robot-assisted surgery, the development of single-use endoscopes, the rise in demand for minimally invasive procedures, and an increase in product launches by market players.

Factors driving market growth include the rising prevalence of chronic gastrointestinal diseases, particularly gastrointestinal cancers, and the adoption of advanced technologies like wireless capsule endoscopy and disposable endoscopes. Disposable endoscopes offer advantages such as infection prevention and cost-effectiveness compared to reusable counterparts, leading to their development by major players.

On the demand side, drivers for the market include the increasing prevalence of chronic gastrointestinal diseases, the adoption of disposable endoscopes, the preference for minimally invasive procedures, and the shift towards wireless capsule endoscopy. Limitations include a shortage of skilled healthcare professionals and the lack of reimbursement frameworks.

Segmentazione del mercato

Il mercato è segmentato in base a vari fattori, including type, end user, e regione.

Segmentazione per tipo
Gastrointestinal Endoscopes and Endoscopic Systems – Capsule Endoscopes, Gastrointestinal Videoscopes, and Visualization Systems
Gastrointestinal Endotherapy – Ultrasound Endoscopes, Balloon Dilators, Gastrointestinal Stents, Biopsy Devices, Retrieval Devices, ERCP Devices, Hemostasis Devices, and Others

Segmentation by End User
Ospedali
Ambulatory Surgery Centers
Altri

Segmentazione per regione
Nord America – U.S. and Canada
Europa – Germania, Francia, U.K., Italia, Spagna, e Resto d'Europa
Asia-Pacifico – Giappone, Cina, India, Australia and New Zealand, Corea del Sud, e resto dell'Asia-Pacifico
America Latina – Argentina, Brasile, Messico, and Rest-of-Latin America
Medio Oriente e Africa – K.S.A., U.A.E., and Rest-of-Middle East and Africa

The gastrointestinal endoscopy market is expected to be predominantly led by the gastrointestinal endoscopes and endoscopic systems segment. This global market is further divided into two main segments: gastrointestinal endoscopes and endoscopic systems, and gastrointestinal endotherapy. The former consists of endoscopic devices used for diagnostic purposes, while the latter includes surgical instruments and devices used for surgical procedures to treat detected indications. As of 2021, the endotherapy segment holds a larger share in the global gastrointestinal endoscopy market, valued at $7,236 milioni, compared to the endoscopes and endoscopic systems segment, valued at $6,172 milioni.

Tuttavia, the endoscopes and endoscopic systems segment is projected to grow at a CAGR of 7.15% during the forecast period of 2022-2031. This growth can be attributed to the increasing awareness among the population regarding the screening of chronic gastrointestinal diseases, especially gastrointestinal cancers like colorectal cancer.

The gastrointestinal endoscopes and endoscopic systems segment can be further categorized into gastrointestinal videoscopes, capsule endoscopes, and visualization systems. The introduction of gastrointestinal videoscopes, along with visualization systems such as light sources, cameras, monitors, e altri, has significantly transformed the landscape of the gastrointestinal endoscopy market. Previously, rigid and fiberoptic endoscopes were the primary options for diagnosing and treating gastrointestinal indications. Tuttavia, their usage has diminished with the advent of gastrointestinal videoscopes. Major players offering various gastrointestinal videoscopes and visualization systems include Olympus Corporation, HOYA Corporation, and FUJIFILM Holdings Corporation, among others.

In terms of end users, the hospital segment dominates the global gastrointestinal endoscopy market. Hospitals account for a major share due to the uptake of endoscopic procedures by private hospitals. Given the cost-intensive nature of gastrointestinal endoscopy and associated accessories, as well as the steep learning curve for surgeons, these minimally invasive procedures are mostly affordable and accessible to high-end multispecialty private hospitals and clinics. Public healthcare centers often face financial constraints in this regard. Tuttavia, there is a shift toward reducing healthcare costs by moving inpatient procedures to outpatient centers, which is gradually changing this trend.

North America stands as the dominant region in the gastrointestinal endoscopy market, owing to superior healthcare systems, advanced infrastructure, high adoption rates of new technology, increased demand for minimally invasive surgeries, and the high efficacy and low relapse rate associated with endoscopic procedures. In 2021, North America held the largest share of 38.97% in the global market, primarily due to the presence of major players and technological advancements. Major U.S.-based players in the gastrointestinal endoscopy market include Medtronic plc, Boston Scientific Corporation, Cook Group Inc, and Teleflex Incorporated.

Panorama competitivo

The selection of the profiled companies was based on inputs obtained from primary experts, as well as an analysis of their company coverage, portafoglio prodotti, e penetrazione del mercato.

Key companies profiled in this report include Boston Scientific Corporation, Medtronic plc, KARL STORZ SE & Co. KG, Ambu A/S, Teleflex Incorporated, HOYA Corporation, Olympus Corporation, FUJIFILM Holdings Corporation, Cook Group Inc, SonoScape Medical Corp., EndoMed Systems GmbH, CapsoVision, Inc., HuiZhou Xzing Technology Co., Ltd., Endogene Ltd., Envaste Limited.

Recenti sviluppi del settore

A maggio 2022, Limaca-Medical obtained breakthrough device recognition from the FDA for its Precision-GI endoscopic ultrasound biopsy device.

A febbraio 2022, Ambu A/S received FDA approval for its Ambu aScope Gastro and Ambu aBox 2.

In November 2021, Medtronic plc received 510(k) clearance from the FDA for its Pillcam Small Bowel 3 system, enabling remote endoscopy procedures.

In August 2021, Ambu received CE mark approval for its Ambu aScope Duodeno, which is a disposable duodenoscope.

Risposte alle domande chiave

What are the primary drivers, limitations, and opportunities for the global gastrointestinal endoscopy market?

What are some key strategies implemented by major players in the market?

Who are the main key players in the global gastrointestinal endoscopy market?

How has the COVID-19 pandemic impacted the global gastrointestinal endoscopy market, and what is the expected duration of this impact on the market?

Why is the global gastrointestinal endoscopy market transitioning from reusable endoscopes to disposable ones?

Why is the global gastrointestinal endoscopy market shifting from open surgeries to robot-assisted surgeries?

What are the significant trends in the field of global gastrointestinal endoscopy, and how will they affect the market in the future?

What are the ongoing clinical trials in the global gastrointestinal endoscopy market?